US Stock MarketDetailed Quotes
SEEL Seelos Therapeutics
- 0.3130
- -0.0263-7.75%
Trading May 6 12:15 ET
5.20MMarket Cap-40P/E (TTM)
0.3700High0.3118Low298.21KVolume0.3570Open0.3393Pre Close102.96KTurnover1.83%Turnover RatioLossP/E (Static)16.61MShares49.800052wk High-0.16P/B5.11MFloat Cap0.270552wk Low--Dividend TTM16.33MShs Float3172500.0000Historical High--Div YieldTTM17.15%Amplitude0.2705Historical Low0.3450Avg Price1Lot Size
About Seelos Therapeutics Company
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Company Profile
SymbolSEEL
Company NameSeelos Therapeutics
Listing DateApr 26, 2000
Founded1987
CEODr. Raj Mehra, PhD
MarketNASDAQ
Employees16
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address300 Park Avenue,2nd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10022
Phone1-646-293-2100
Company Executives
- Name
- Position
- Salary
- Dr. Raj Mehra, PhD
- Chairman of the Board, Chief Executive Officer and President
- 2.46M
- Michael Golembiewski
- Chief Financial Officer and Principal Accounting Officer
- 1.07M
- Daniel J. O'Connor, J.D.
- Independent Director
- 87.82K
- Richard W. Pascoe
- Independent Director
- 95.83K
- Dr. Margaret Dalesandro, PhD
- Independent Director
- 88.96K
- Dr. Brian Lian, PhD
- Independent Director
- 115.27K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg